Originally identified as a co‐receptor for HIV‐1 in CD4+ T cell infection [38], CXCR4 expression has been detected in numerous cancer cells [39], often overexpressed at tumour sites alongside elevated stromal tissue CXCL12 levels. Here, CXCL12 is linked to neoplasm.